From Cambridge to Taipei, SmartLabs’ Universal Lab Framework became an international case study in how public and private sectors can co-build scientific infrastructure.

I provided a formal statement to members of the U.S. House of Representatives during a congressional briefing on the modernization of America’s biomedical infrastructure and the critical role of private-sector innovation in shaping its future.

SmartLabs’ $250 million Series B transformed a regional operator into a national platform — backed by investors who treated infrastructure itself as a new class of technology.

SmartLabs opened new GxP-compliant animal research and manufacturing suites in Boston—fully leased upon launch.

Investor-focused coverage of SmartLabs’ Series B round, detailing growth strategy and investor participation.

The official release detailing SmartLabs’ funding round and unveiling Lab OS—an integrated digital backbone connecting design, operations, and data management across sites.

Coverage of SmartLabs’ landmark $250 million Series B financing, enabling national growth and technological advancement across its laboratory network.

Coverage of SmartLabs’ first major Bay Area expansion at the Genesis South San Francisco campus, establishing a permanent West Coast presence.

SmartLabs, a first-of-its-kind laboratory-as-a-service company, announced its national expansion into South San Francisco.

An analysis of how limited space in Kendall Square fueled the rise of shared laboratory infrastructure — with SmartLabs at the center of the conversation.